• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation
Definition For the treatment of atrial fibrillation.
Product CodeQZI
Device Class 3

Premarket Approvals (PMA)
2021 2022 2023 2024 2025 2026
0 0 1 16 40 52

Recalls
Manufacturer Recall Class Date Posted
1 Biosense Webster, Inc. I Feb-28-2025
2 Boston Scientific Corporation II Jul-17-2026
3 Boston Scientific Corporation II Jul-17-2026
4 Boston Scientific Corporation II Aug-08-2025
-
-